Skip to content
DataLookout
Menu

NCT06934096

Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 1 year 1 month later across 2 updates.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 65 words
    • Primary completion pushed from Jan 7, 2027 to Jun 7, 2027
    • Study completion pushed from Jan 31, 2027 to Aug 31, 2027
    • Site contact updated
  2. Notable Primary completion pushed from Apr 21, 2026 to Jan 7, 2027v2 Show 4 more changesShow less
    • Recruitment opened
    • Start date changed from estimate of Apr 15, 2025 to Jan 8, 2026
    • Study completion pushed from May 12, 2026 to Jan 31, 2027
    • Site details revised
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

To determine whether diagnostic-level ultrasound to the spleen can modulate systemic blood biomarkers of hemostasis
Timeframe: 4 hours

Arms and interventions

Focused insonification at enter of spleenExperimental
Prolonged duration Insonification at center of spleenExperimental
Prolonged insonification swept across the spleenExperimental

Devices: Ultrasound Pulsed Doppler Imaging System

Sites

1 site in 1 country

  • Feinstein Institute for Medical ResearchManhasset, New York, United States